Causes And Symptoms Of Cataplexy
Published on: February 6, 2025
causes and symptoms of cataplexy
Article author photo

Nowreen Babu

Master's degree, Pharmacology and Biotechnology, <a href="https://www.shu.ac.uk/" rel="nofollow">Sheffield Hallam University</a>

Article reviewer photo

Ana Kuznetsova

BSc Pharmacology, University of Nottingham

Introduction 

Cataplexy is a key symptom of narcolepsy, a sleep disorder, and involves sudden, uncontrollable episodes of muscle weakness or paralysis while the person is awake. During these episodes, the individual is fully conscious but temporarily unable to move. Cataplexy can be very disabling and is often triggered by strong emotions, which can be positive or negative- like laughter or anger. 

It's frequently missed by doctors because it can vary greatly in how and when it shows up, what triggers it, and how frequent and severe the attacks are. 

This condition almost always occurs in people who have lost certain neurons in the brain that produce a chemical called orexin. Scientists believe that cataplexy happens because brain circuits that usually cause muscle relaxation during deep sleep get activated while the person is awake. This muscle weakness is due to less activity in some brain neurons that normally stimulate muscles and more activity in neurons that inhibit muscle movement. 

Emotional triggers, particularly positive ones, are thought to initiate these attacks through pathways in parts of the brain called the amygdala and medial prefrontal cortex. Although there has been significant progress in understanding cataplexy, treatment mainly focuses on managing symptoms, with antidepressants and a medication called γ-hydroxybutyrate being the most effective options.1,2 


Created by Ana Kuznetsova using BioRender

Symptoms 

Cataplexy is characterised by sudden episodes of muscle weakness triggered by strong emotions such as laughter, excitement, surprise or anger. During these episodes, which can last from a few seconds to a couple of minutes, a person might experience drooping eyelids, slurred speech, jaw-dropping, and even collapse to the ground while remaining fully conscious. These episodes vary in frequency and intensity, and they are a common symptom of narcolepsy.3

  • Hypnagogic hallucinations: Many people with cataplexy (71%) experience vivid dream-like images or sounds as they are falling asleep. This happens to fewer people without cataplexy (40%)
  • Sleep paralysis: A significant number of people with cataplexy (69%) find themselves temporarily unable to move or speak when falling asleep or waking up, compared to a smaller percentage (25%) of those without cataplexy
  • Nocturnal Sleep Disturbance: Most people with cataplexy (80%) have trouble staying asleep at night, waking up frequently. This happens to a little over half (55%) of those without cataplexy3,4

Evidence 

In a 1990 study consisting of 107 individuals, 87 had cataplexy, whilst 20 did not. The groups were similar in age and gender, and all had severe daytime sleepiness. Those with cataplexy experienced the following compared to those without cataplexy:

  • More vivid dreams as they were falling asleep 
  • Temporary inability to move or speak when falling asleep or waking up 
  • Frequent night-time awakenings 
  • They reported poorer sleep quality and more frequent awakenings at night 
  • Those with cataplexy also had more REM sleep episodes at sleep onset 
  • Were more likely to take daytime naps and have accidents due to sleepiness 

This suggests that patients with cataplexy have a more severe form of narcolepsy, with more symptoms and greater difficulty staying awake or asleep. The study highlights the importance of considering these differences in diagnosing and researching narcolepsy.3

Status cataplecticus 

Patients may also experience "status cataplecticus," a rare and severe form of narcolepsy where cataplexy episodes can last for several hours each day, effectively confining the person to bed. This condition can happen spontaneously but more commonly occurs when someone stops taking their anti cataplectic medications.5 

Causes 

Cataplexy is like a sudden glitch in the brain's muscle control system. Normally, when you feel strong emotions like laughter or excitement, your brain releases signals that tell your muscles to relax a bit. It's like a temporary loss of muscle strength. But in cataplexy, this signal gets mixed up. The amygdala and medial prefrontal cortex in the brain contain neural pathways through which positive emotions probably trigger cataplectic attacks.

In people without narcolepsy, there are checks and balances in the brain to keep this from causing any problems. But in narcolepsy, there's a missing piece called the orexin system. This missing piece is like the supervisor of muscle control. So, when strong emotions hit, there's nothing to stop the muscle relaxation from going too far, leading to sudden weakness or even collapse. So cataplexy happens because the brain's muscle control system gets confused, especially when there's a lack of a key player called the orexin system.7

The role of orexin

The discovery of hypocretin/orexin loss as the main cause of narcolepsy helped scientists create animal models to understand how this chemical works in the brain. When people with narcolepsy have cataplexy, it's often because they lack enough hypocretin/orexin, which are chemicals made by special cells in the brain. These cells are found in a part of the brain called the tuberal hypothalamus.8 

Hypocretin/orexin isn't just important for controlling sleep and wakefulness; it also has a role in how our brain responds to rewards, like feeling good when we do something we enjoy. In the brainstem, there's a region called the subdorsolateral nucleus (SLD), which normally keeps our muscles relaxed during a specific stage of sleep called REM sleep. In mice experiments, when scientists activated the SLD, it caused cataplexy, and when they turned it off, cataplexy stopped. This shows that the same brain region involved in REM sleep muscle relaxation also affects cataplexy.8 

So, how does cataplexy happen? Well, positive emotions can trigger a part of the brain called the medial prefrontal cortex (mPFC), which then activates other parts like the central nucleus of the amygdala (CeA). These activated parts then shut down other regions like the locus coeruleus (LC), laterodorsal tegmentum (LPT), and ventrolateral periaqueductal grey (vlPAG). When these regions are turned off, it releases the SLD from inhibition, causing muscle relaxation and cataplexy.8

So, in simple terms, cataplexy can be triggered when certain brain areas are activated by positive emotions, leading to a chain reaction that relaxes muscles, and this process is influenced by the level of hypocretin/orexin in the brain.

Other causes

  • The main causes of cataplexy outside of narcolepsy are associated with certain medical conditions, such as Niemann-Pick type C syndrome. These conditions can lead to episodes of cataplexy even without the presence of excessive daytime sleepiness (EDS), which is a hallmark symptom of narcolepsy 
  • Medications can sometimes induce cataplexy as a side effect 

Understanding these potential causes is crucial for accurately diagnosing and managing cataplexy, especially in specific populations like children with genetic conditions. 

Overall, further research is needed to better understand the underlying mechanisms of cataplexy and improve diagnosis and treatment strategies.6

Treatment and medication 

Despite major advances in understanding disease mechanisms in cataplexy, therapeutic management is largely symptomatic, with antidepressants and γ-hydroxybutyrate being the most effective treatments.

The first medications used to treat cataplexy were TCAs (tricyclic antidepressants). They were found to reduce cataplexy, sleep paralysis, and hallucinations that occur during sleep. 

One TCA, clomipramine, is particularly effective because it targets serotonin reuptake and suppresses REM sleep. The typical dose of clomipramine for cataplexy is between 25 to 75 mg daily, although higher doses may be used. Clomipramine can start reducing cataplexy within 48 hours, but some patients may develop tolerance after several weeks. 

Common side effects of TCAs include: 

  • Dry mouth 
  • Constipation 
  • Tachycardia 
  • Men may also experience sexual side effects like decreased libido or impotence 
  • Abruptly stopping TCA treatment can lead to severe rebound cataplexy 

TCAs should be used cautiously in patients with heart conditions, seizure disorders, or glaucoma due to their effects on cardiac conduction, seizure threshold, and eye pressure.9

Over time, cataplexy generally improves, often becoming less frequent or severe with age. In rare instances, it may disappear entirely, but typically it becomes more manageable as patients learn to better control their emotions.5 

Summary 

Cataplexy is a key symptom of narcolepsy, a sleep disorder characterised by sudden episodes of muscle weakness or paralysis while a person is awake. These episodes are often triggered by strong emotions like laughter, excitement, or anger. During an episode, individuals remain fully conscious but temporarily lose control of their muscles. 

Symptoms can vary in frequency, intensity, and duration, making diagnosis challenging. The main cause of cataplexy in narcolepsy is the loss of certain neurons in the brain that produce a chemical called orexin. These neurons are located in the tuberal hypothalamus and play a crucial role in regulating sleep-wake cycles, arousal, and muscle tone. Without enough orexin, brain circuits responsible for muscle relaxation during deep sleep can get activated while a person is awake, leading to cataplexy. 

Positive emotions, particularly laughter, trigger cataplexy through neural pathways involving the amygdala and medial prefrontal cortex. These emotions activate certain brain regions, leading to inhibition of areas that normally stimulate muscles and increased activity in areas that inhibit muscle movement. This imbalance results in muscle weakness or paralysis characteristic of cataplexy. 

Treatment for cataplexy mainly focuses on managing symptoms. Antidepressants and γ-hydroxybutyrate are commonly used and have shown effectiveness in reducing the frequency and severity of episodes. However, therapeutic management remains largely symptomatic, and further research is needed to develop more targeted treatments. 

Outside of narcolepsy, cataplexy can also be caused by certain medical conditions or medications. Understanding these potential causes is essential for accurate diagnosis and management, particularly in specific populations like children with genetic conditions.

References

  • Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nature Reviews Neurology. 2014 Jul;10(7):386-95.
  • Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. The Lancet. 2007 Feb 10;369(9560):499-511.
  • Rosenthal LD, Zorick FJ, Merlotti L, Wittig RM, Roehrs TA, Roth T. Signs and symptoms associated with cataplexy in narcolepsy patients. Biological psychiatry. 1990 May 1;27(9):1057-60.
  • Reading P. Cataplexy. Practical Neurology. 2019 Feb 1;19(1):21-7.
  • Nishino S, Mignot E. Narcolepsy and cataplexy. Handbook of clinical neurology. 2011 Jan 1;99:783-81
  • Lima FC, do Nascimento Junior EB, Teixeira SS, Coelho FM, da Paz Oliveira G. Thinking outside the box: cataplexy without narcolepsy. Sleep Medicine. 2019 Sep 1;61:118-21.
  • Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. Journal of Neuroscience. 2012 Sep 5;32(36):12305-11.
  • Heidbreder A, Dirks C, Ramm M. Therapy for Cataplexy. Current Treatment Options in Neurology. 2020 Apr;22:1-3.
  • Lopez R, Dauvilliers Y. Pharmacotherapy options for cataplexy. Expert opinion on pharmacotherapy. 2013 May 1;14(7):895-903.
Share

Nowreen Babu

Master's degree, Pharmacology and Biotechnology, Sheffield Hallam University

Nowreen Babu is a dedicated pharmacist with experience in both retail and hospital settings, specializing in safe and effective medication use. Currently pursuing a Masters in Pharmacology and Biotechnology at Sheffield Hallam University, Nowreen is passionate about healthcare collaboration and patient education. With a background in pharmacy operations and medication management, Nowreen brings expertise in prescription dispensing and medication counseling to the field. Nowreen's commitment to enhancing healthcare outcomes through informed medication practices underscores a career marked by continuous learning and professional growth.

arrow-right